131 related articles for article (PubMed ID: 20709009)
21. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
22. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
23. Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice.
Toobak H; Rasooli I; Talei D; Jahangiri A; Owlia P; Darvish Alipour Astaneh S
Biologicals; 2013 Jul; 41(4):224-30. PubMed ID: 23796754
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
26. Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion.
Yamazaki S; Machii K; Tsuyuki S; Momose H; Kawashima T; Ueda K
Immunology; 1985 Sep; 56(1):43-50. PubMed ID: 4043995
[TBL] [Abstract][Full Text] [Related]
27. Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice.
Nishikawa F; Kita E; Yamada H; Nakano A; Kashiba S
Microbiol Immunol; 1994; 38(2):129-37. PubMed ID: 8041300
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice.
Takei S; Omoto C; Kitagawa K; Morishita N; Katayama T; Shigemura K; Fujisawa M; Kawabata M; Hotta H; Shirakawa T
Vaccine; 2014 May; 32(25):3066-74. PubMed ID: 24657718
[TBL] [Abstract][Full Text] [Related]
29. Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever.
Martins FS; Elian SD; Vieira AT; Tiago FC; Martins AK; Silva FC; Souza EL; Sousa LP; Araújo HR; Pimenta PF; Bonjardim CA; Arantes RM; Teixeira MM; Nicoli JR
Int J Med Microbiol; 2011 Apr; 301(4):359-64. PubMed ID: 21236729
[TBL] [Abstract][Full Text] [Related]
30. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.
McSorley SJ; Jenkins MK
Infect Immun; 2000 Jun; 68(6):3344-8. PubMed ID: 10816483
[TBL] [Abstract][Full Text] [Related]
31. Further studies of protective activity of antigen complexes of typhoid and paratyphoid B vaccines.
Hejfec LB; Stanislavskij ES; Levina LA
Prog Immunobiol Stand; 1971; 5():389-93. PubMed ID: 4573947
[No Abstract] [Full Text] [Related]
32. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines.
Kita E; Nishikawa F; Kamikaidou N; Oku D; Yasui K; Kashiba S
FEMS Microbiol Immunol; 1992 Oct; 5(4):191-9. PubMed ID: 1419117
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a
Zafar H; Rahman SU; Ali S; Javed MT
Pol J Microbiol; 2019; 68(2):173-183. PubMed ID: 31257790
[TBL] [Abstract][Full Text] [Related]
34. Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid.
Kinnear CL; Strugnell RA
PLoS One; 2015; 10(10):e0141356. PubMed ID: 26509599
[TBL] [Abstract][Full Text] [Related]
35. Oral co-administration of bivalent protein r-BL with U-Omp19 elicits mucosal immune responses and reduces S. Typhimurium shedding in BALB/c mice.
Nikam PS; Kingston JJ; Belagal Motatis AK
Immunol Lett; 2021 Mar; 231():61-67. PubMed ID: 33460704
[TBL] [Abstract][Full Text] [Related]
36. Immunity to intracellular Salmonella depends on surface-associated antigens.
Barat S; Willer Y; Rizos K; Claudi B; Mazé A; Schemmer AK; Kirchhoff D; Schmidt A; Burton N; Bumann D
PLoS Pathog; 2012; 8(10):e1002966. PubMed ID: 23093937
[TBL] [Abstract][Full Text] [Related]
37. Suggested adoption of a non-motile variant of strain Ty 2 for vaccination against typhoid fever.
Anderson ES
Prog Immunobiol Stand; 1971; 5():373-7. PubMed ID: 4573944
[No Abstract] [Full Text] [Related]
38. Conversion of Salmonella typhimurium to L-forms contributes to the maintenance of acquired immunity against murine typhoid.
Kita E; Emoto M; Nishikawa F; Yoshikai Y; Kashiba S
Immunology; 1995 Oct; 86(2):206-11. PubMed ID: 7490119
[TBL] [Abstract][Full Text] [Related]
39. Dual immunization with CdtB protein and flagellin epitope offers augmented protection against enteric fever in mice.
Vij S; Thakur R; Singh RP; Kumar R; Pathania P; Gupta V; Suri CR; Rishi P
Life Sci; 2023 Dec; 334():122216. PubMed ID: 37918629
[TBL] [Abstract][Full Text] [Related]
40. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen.
Rollenhagen C; Sörensen M; Rizos K; Hurvitz R; Bumann D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8739-44. PubMed ID: 15173591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
